Sector: Biopharmaceutical Supply Chain
Description: Cell and Gene Therapy Contract Manufacturing
Investment Date: 2018
Headquarters: Charleroi, Belgium
Founded in 2011 and based in Charleroi, Belgium, MaSTherCell leverages its world-class facilities, regulatory track record and technical expertise to maintain a leading position as a global manufacturer of cell and gene therapies. From technology transfer to end logistics, the Company provides a wide range of services to help biotechnology companies develop and produce their novel drugs. MaSTherCell has facilities in Belgium, South Korea, Israel, and following the GPP investment, will build an additional facility in the United States.